European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables
Open Access
- 23 April 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (5) , 879-882
- https://doi.org/10.1038/sj.bjc.6690435
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Molecular Cloning and Characterization ofLOH11CR2A,a New Gene within a Refined Minimal Region of LOH at 11q23Genomics, 1997
- Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25Science, 1997
- Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint KinaseScience, 1997
- Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regionsOncogene, 1997
- A Yeast Artificial Chromosome Contig andNotI Restriction Map That Spans the Tumor Suppressor Gene(s) Locus, 11q22.2–q23.3Genomics, 1996
- A Human Gene (DDX10) Encoding a Putative DEAD-Box RNA Helicase at 11q22–q23Genomics, 1996
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995
- A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 KinaseScience, 1995
- Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.Proceedings of the National Academy of Sciences, 1991
- Hypervariable polymorphism in the APOC3 geneNucleic Acids Research, 1991